Dialysis provider Fresenius creates regenerative medicine biz

Fresenius Medical Care is planning for beyond dialysis. It's created a new regenerative medicine subsidiary, known as Unicyte, with partner University of Turin. It has a long-standing relationship with the university that dates back to 2003. Unicyte will do research into the application of regenerative medicine to kidney and liver diseases, diabetes and cancer. The transfer of liver stem cells into other cell types as well as the creation of functional pancreatic islets are some of the research projects it will undertake. More

Suggested Articles

Millions of tests are urgently needed as the virus keeps communities across the country in lockdown and hospitals are overwhelmed with patients.

The FDA granted its first emergency authorization for a rapid antibody blood test for COVID-19 developed by Cellex.

The ultimate goal is to move as many patients as possible out of the clinic that don’t need immediate, critical care.